Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Life Sciences Research Partners Vzw
Life Sciences Research Partners Vzw lsrp
  

Life Sciences Research Partners Vzw patents

Recent patent applications related to Life Sciences Research Partners Vzw. Life Sciences Research Partners Vzw is listed as an Agent/Assignee. Note: Life Sciences Research Partners Vzw may have other listings under different names/spellings. We're not affiliated with Life Sciences Research Partners Vzw, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "L" | Life Sciences Research Partners Vzw-related inventors




Date Life Sciences Research Partners Vzw patents (updated weekly) - BOOKMARK this page
07/27/17 new patent  Liver-specific nucleic acid regulatory elements and methods and use thereof
04/13/17Strategies to prevent and/or treat immune responses to soluble allofactors
03/09/17Responsiveness to angiogenesis inhibitors
07/07/16Extracellular allosteric inhibitor binding domain from a tyrosine kinase receptor
07/07/16Immunogenic peptides and their use in immune disorders
06/16/16Carnitine palmitoyltransferase 1 inhibitors for inhibition of pathological angiogenesis
06/09/16Pyrimidine hydroxy amide compounds for treating peripheral neuropathy
04/28/16Single domain antibodies against sod1 and their use in medicine
03/03/16Minimally toxic prodrugs
01/07/16Hdac inhibitors to treat charcot-marie-tooth disease
09/17/15Modulating transendothelial migration and recruitment of granulocytes by modulating c-met pathway
08/06/15Elimination of immune responses to viral vectors
04/23/15Immunogenic control of tumours and tumour cells
02/12/15Novel markers for detecting microsatellite instability in cancer and determining synthetic lethality with inhibition of the dna base excision repair pathway
01/01/15Responsiveness to angiogenesis inhibitors
12/25/14Immunotherapy targeting intracellular pathogens
12/18/14Modified epitopes for boosting cd4+ t-cell responses
10/02/14Method for predicting risk of hypertension associated with anti-angiogenesis therapy
07/03/14Cd4+ t-cells with cytolytic properties
08/29/13Hdac inhibitors to treat charcot-marie-tooth disease
05/30/13Antibodies which bind factor viii
03/24/11Use of survivin to treat kidney failure
06/17/10Treatment of amyotrophic lateral sclerosis
02/19/09Inhibitors of prolyl-hydroxylase 1 for the treatment of skeletal muscle degeneration
09/24/09Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage
06/25/09Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage
03/19/09Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Life Sciences Research Partners Vzw in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Life Sciences Research Partners Vzw with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';